{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:35:33Z","timestamp":1772829333162,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National University of Pharmacy"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ejmech.2019.06.085","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T19:28:48Z","timestamp":1562095728000},"page":"134-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Synthesis, in\u00a0vivo and in silico anticonvulsant activity studies of new derivatives of 2-(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)acetamide"],"prefix":"10.1016","volume":"180","author":[{"given":"Wassim Mokhamad","family":"El Kayal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergiy Yu","family":"Shtrygol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergiy V.","family":"Zalevskyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amjad abu","family":"Shark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vadim V.","family":"Tsyvunin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergiy M.","family":"Kovalenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalya D.","family":"Bunyatyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina O.","family":"Perekhoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2894-9384","authenticated-orcid":false,"given":"Hanna I.","family":"Severina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8794-8010","authenticated-orcid":false,"given":"Victoriya A.","family":"Georgiyants","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejmech.2019.06.085_bib1","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","article-title":"Global, regional, and national burden of neurological disorders during 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"16","author":"GBD 2015 Neurological Disorders Collaborator Group","year":"2017","journal-title":"Lancet Neurol."},{"issue":"4 suppl 1","key":"10.1016\/j.ejmech.2019.06.085_bib2","first-page":"1","article-title":"Summary of antiepileptic drugs Available in the United States of America: working toward a world without epilepsy","volume":"18","author":"Vossler","year":"2018","journal-title":"Am. Epilepsy Soc. Treat. Comm. Epilepsy Curr."},{"key":"10.1016\/j.ejmech.2019.06.085_bib3","first-page":"15","article-title":"Marketing researches of market on medications for neuroprotective action in Ukraine","volume":"1","author":"Kotvitska","year":"2013","journal-title":"Acta Fac. Pharm. Univ. Comen. LX"},{"issue":"2","key":"10.1016\/j.ejmech.2019.06.085_bib4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.mcna.2018.10.002","article-title":"Seizures and epilepsy","volume":"103","author":"Emily","year":"2019","journal-title":"Med. Clin. N. Am."},{"issue":"2","key":"10.1016\/j.ejmech.2019.06.085_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.clinph.2018.11.016","article-title":"Resting state connectivity in neocortical epilepsy: the epilepsy network as a patient-specific biomarker","volume":"130","author":"Marino","year":"2019","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.ejmech.2019.06.085_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/B978-012373961-2.00074-6","article-title":"Anticonvulsant drugs as neuronal network-modifying agents","volume":"1","author":"Faingold","year":"2009","journal-title":"Encycl. Basic Epilepsy Res."},{"key":"10.1016\/j.ejmech.2019.06.085_bib7","first-page":"42","article-title":"Antiepileptic drugs in development pipeline: a recent update","volume":"4","author":"Kaur","year":"2016","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ejmech.2019.06.085_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pharmthera.2006.07.005","article-title":"Novel anticonvulsant drugs","volume":"113","author":"Stefan","year":"2007","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.ejmech.2019.06.085_bib9","first-page":"2064027","article-title":"Mechanisms underlying aggressive behavior induced by antiepileptic drugs: focus on topiramate, levetiracetam, and perampanel","author":"Hansen","year":"2018","journal-title":"Behav. Neurol."},{"issue":"02","key":"10.1016\/j.ejmech.2019.06.085_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7324\/JAPS.2019.90202","article-title":"Synthesis and anticonvulsant activity of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one acetamides","volume":"9","author":"Severina","year":"2019","journal-title":"J.\u00a0Appl. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2019.06.085_bib11","first-page":"404","article-title":"An updated review: emerging anticonvulsants","volume":"1","author":"Siddqui","year":"2010","journal-title":"Int. J. Pharm. Biosci. Arch."},{"key":"10.1016\/j.ejmech.2019.06.085_bib12","article-title":"Treatment for methaqualone dependence in adults","volume":"2","author":"Carthy","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejmech.2019.06.085_bib13","first-page":"703","article-title":"Design and synthesis of novel quinazolinone derivatives as broad spectrum anticonvulsant and antimicrobial agent","volume":"3","author":"Ilangovan","year":"2010","journal-title":"J.\u00a0Pharm. Res."},{"issue":"10","key":"10.1016\/j.ejmech.2019.06.085_bib14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ejmech.2014.04.072","article-title":"Quinazolines: new horizons in anticonvulsant therapy","volume":"80","author":"Ugale","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.085_bib15","first-page":"101","article-title":"Design, synthesis, molecular docking and anticonvulsant evaluation of novel 6-iodo-2-phenyl-3-substituted-quinazoli-4(3H)-ones","volume":"53","author":"Ibrahim","year":"2015","journal-title":"Bull. Fac. Pharm. Cairo Univ."},{"issue":"1","key":"10.1016\/j.ejmech.2019.06.085_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2019.06.085_bib17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature13293","article-title":"Crystal structure of a human gabaa receptor","volume":"512","author":"Miller","year":"2014","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ejmech.2019.06.085_bib18","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.4155\/fmc.11.69","article-title":"Carbonic anhydrase inhibitors and activators for novel therapeutic applications","volume":"3","author":"Supuran","year":"2011","journal-title":"Future Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2019.06.085_bib19","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1021\/acsmedchemlett.8b00352","article-title":"Tuning the dual inhibition of carbonic anhydrase and cyclooxygenase by dihydrothiazole benzensulfonamides","volume":"9","author":"Meleddu","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.06.085_bib20","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3109\/14756366.2015.1063624","article-title":"Coumarin or benzoxazinone based novel carbonic anhydrase inhibitors: synthesis, molecular docking and anticonvulsant studies","volume":"31","author":"Karata\u015f","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.085_bib21","first-page":"437","article-title":"Crystal structure of human carbonic anhydrase II complexed with anticonvulsant sugar sulfamate","volume":"22","author":"Recacha","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.06.085_bib22","series-title":"Drug Discovery and Evaluation: Pharmacological Assays","first-page":"459","author":"Vogel","year":"2008"},{"key":"10.1016\/j.ejmech.2019.06.085_bib23","series-title":"\u0420\u0443\u043a\u043e\u03d1\u043e\u0434\u0441\u0442\u03d1\u043e \u043f\u043e \u043f\u0440\u043e\u03d1\u0435\u0434\u0435\u043d\u0438\u044e \u0434\u043e\u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u03d1\u0430\u043d\u0438\u0439 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u03d1\u0435\u043d\u043d\u044b\u0445 \u0441\u0440\u0435\u0434\u0441\u0442\u03d1. \u0427\u0430\u0441\u0442\u044c \u043f\u0435\u0440\u03d1\u0430\u044f","first-page":"944","author":"\u041c\u0438\u0440\u043e\u043d\u043e\u03d1\u0430","year":"2012"},{"key":"10.1016\/j.ejmech.2019.06.085_bib24","series-title":"\u041c\u043e\u0434\u0443\u043b\u044f\u20db\u0438\u044f \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u044d\u0444\u0444\u0435\u043a\u0442\u043e\u03d1 \u043f\u0440\u0438 \u0440\u0430\u0437\u043b\u0438\u0447\u043d\u044b\u0445 \u0441\u043e\u043b\u0435\u03d1\u044b\u0445 \u0440\u0435\u0436\u0438\u043c\u0430\u0445: \u041c\u043e\u043d\u043e\u0433\u0440\u0430\u0444\u0438\u044f","first-page":"360","author":"\u0428\u0442\u0440\u044b\u0433\u043e\u043b\u044c","year":"2007"},{"key":"10.1016\/j.ejmech.2019.06.085_bib25","first-page":"46","article-title":"\u042d\u043a\u0441\u043f\u0440\u0435\u0441\u0441-\u043c\u0435\u0442\u043e\u0434 \u043e\u043f\u0440\u0435\u0434\u0435\u043b\u0435\u043d\u0438\u044f \u0441\u0440\u0435\u0434\u043d\u0435 \u0441\u043c\u0435\u0440\u0442\u0435\u043b\u044c\u043d\u044b\u0445 \u0434\u043e\u0437 \u0445\u0438\u043c\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u03d1\u0435\u266f\u0435\u0441\u0442\u03d1","volume":"6","author":"\u041f\u0430\u0441\u0442\u0443\u266f\u0435\u043d\u043a\u043e","year":"1985","journal-title":"\u0413\u0438\u0433\u0438\u0435\u043d\u0430 \u0438 \u0441\u0430\u043d\u0438\u0442\u0430\u0440\u0438\u044f."},{"key":"10.1016\/j.ejmech.2019.06.085_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/09-SS051","article-title":"Wilcoxon\u2013Mann\u2013Whitney or t-test? On assumptions for hypothesis tests and multiple interpretations of decision rules","volume":"4","author":"Fay","year":"2010","journal-title":"Stat. Surv."},{"issue":"6","key":"10.1016\/j.ejmech.2019.06.085_bib27","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1006\/anbe.2001.1691","article-title":"Mann\u2013Whitney U test when variances are unequal","volume":"61","author":"Kasuya","year":"2001","journal-title":"Anim. Behav."},{"issue":"2","key":"10.1016\/j.ejmech.2019.06.085_bib28","first-page":"77","article-title":"Studies on the medicinal chemistry of oxoquinazolines. I. N-(Arylcarbamoylmethyl)- and N-(4-t-amino-2-butynyl) derivatives of 1,2,3,4-tetrahydro-2,4-dioxoquinazoline","volume":"5","author":"Danielsson","year":"1968","journal-title":"Acta Pharm. Suec."},{"key":"10.1016\/j.ejmech.2019.06.085_bib29","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1021\/ja02233a023","article-title":"Researches on quinazolines. XXXIV. The synthesis of certain nitro and amino benzoylene ureas and some compounds related thereto","volume":"31","author":"Bogert","year":"1919","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"7","key":"10.1016\/j.ejmech.2019.06.085_bib30","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/hlca.200590135","article-title":"Application of the \"direct amide cyclization\" to peptides containing an anthranilic acid residue","volume":"88","author":"Philipova","year":"2005","journal-title":"Helv. Chim. Acta"},{"issue":"3","key":"10.1016\/j.ejmech.2019.06.085_bib31","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/jhet.5570180315","article-title":"Reactions of o-aminonitriles with isocyanates. 2. A facile synthesis of imidazo[1,2c]quinazoline-2,5-(3H,6H)dione","volume":"18","author":"Papadopoulos","year":"1981","journal-title":"J.\u00a0Heterocycl. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2019.06.085_bib32","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3987\/COM-92-6296","article-title":"Synthesis of chiral 3-substituted 2,4(1H,3H)-Quinazolinediones","volume":"36","author":"Canonne","year":"1993","journal-title":"Heterocycles"},{"issue":"6","key":"10.1016\/j.ejmech.2019.06.085_bib33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1021\/cc020097g","article-title":"Synthesis of substitu-ted 4-Oxo-2-thioxo-1,2,3,4-tetrahydroquinazolines and 4-Oxo-3,4-dihydroquinazoline-2-thioles","volume":"5","author":"Ivachtchenko","year":"2003","journal-title":"J.\u00a0Comb. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2019.06.085_bib34","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1080\/00397911.2010.518331","article-title":"Efficient synthesis of primary amides from carboxylic acids using N,N\u2032-Carbonyldiimidazole and ammonium acetate in ionic liquid","volume":"41","author":"Soo Lee Kwan","year":"2011","journal-title":"Synth. Commun."},{"issue":"6","key":"10.1016\/j.ejmech.2019.06.085_bib35","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/00397910903026723","article-title":"Synthesis of hydroxamic acids by activation of carboxylic acids with N,N\u2032-Carbonyldiimidazole: exploring the efficiency of the method","volume":"40","author":"Usachova","year":"2010","journal-title":"Synth. Commun."},{"issue":"16","key":"10.1016\/j.ejmech.2019.06.085_bib36","first-page":"1116","article-title":"Synthesis and anticonvulsant screening of 1,2,4-triazole derivatives","volume":"70","author":"Suat","year":"2018","journal-title":"Pharmacol. Rep."},{"issue":"7","key":"10.1016\/j.ejmech.2019.06.085_bib37","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/acs.jcim.7b00721","article-title":"Searching for new leads to treat epilepsy: target-based virtual screening for the Discovery of anticonvulsant agents","volume":"58","author":"Palestro","year":"2018","journal-title":"J.\u00a0Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.ejmech.2019.06.085_bib38","first-page":"101","article-title":"Design, synthesis, molecular docking and anticonvulsant evaluation of novel 6-iodo-2-phenyl-3-substituted-quinazolin-4(3H)-ones","volume":"53","author":"Ibrahim","year":"2015","journal-title":"Bull. Fac. Pharm. Cairo Univ."},{"issue":"01","key":"10.1016\/j.ejmech.2019.06.085_bib39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.7324\/JAPS.2019.90110","article-title":"Docking studies of biologically active substances from plant extracts with anticonvulsant activity","volume":"9","author":"Prokopenko","year":"2019","journal-title":"J.\u00a0Appl. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejmech.2019.06.085_bib40","first-page":"93","article-title":"Tabulation of toxicity classes","volume":"10","author":"Hodge","year":"1943","journal-title":"Am. Ind. Hyg. Ass. Quart."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419306129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419306129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:56:21Z","timestamp":1759326981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419306129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":40,"alternative-id":["S0223523419306129"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.06.085","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, in\u00a0vivo and in silico anticonvulsant activity studies of new derivatives of 2-(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)acetamide","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.06.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}